⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

RPTX News

Repare Therapeutics Inc. Common Shares

Repare Therapeutics to Present Initial Data from Phase 1 LIONS Clinical Trial at 37th AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics